Pfizer’s Lyrica: “Approvable” For Three Indications, Not Generalized Anxiety
Executive Summary
Pfizer's Lyrica (pregabalin) is "approvable" for three of four requested indications
You may also be interested in...
Pfizer Lyrica Launch Awaits Controlled Substance Scheduling
Pfizer's launch of Lyrica will be delayed while pregabalin undergoes controlled substance scheduling at the Drug Enforcement Administration
Pfizer Lyrica Launch Awaits Controlled Substance Scheduling
Pfizer's launch of Lyrica will be delayed while pregabalin undergoes controlled substance scheduling at the Drug Enforcement Administration
Cymbalta “Mood” And “Pain” Claims May Include Fibromyalgia And Anxiety
Lilly is pursuing fibromyalgia and generalized anxiety disorder indications to add to the two currently approved indications for Cymbalta